KROS – keros therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $84.00 price target on the stock.
Keros Therapeutics, Inc. (NASDAQ: KROS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results [Yahoo! Finance]
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2024 Financial Results
Keros Therapeutics to Present at the Guggenheim Healthcare Innovation Conference
Form 4 Keros Therapeutics, Inc. For: Nov 08 Filed by: CHYUNG YUNG H.
Form 3 Keros Therapeutics, Inc. For: Nov 01 Filed by: CHYUNG YUNG H.
Form 10-Q Keros Therapeutics, Inc. For: Sep 30
Form 8-K Keros Therapeutics, Inc. For: Nov 06
Form 8-K Keros Therapeutics, Inc. For: Nov 06
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.